Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Ischemic Heart Disease

  Free Subscription


Articles published in Curr Opin Cardiol

Retrieve available abstracts of 6 articles:
HTML format
Text format



Single Articles


    July 2017
  1. THOMAS MP, Bates ER
    Percutaneous coronary intervention strategies in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease.
    Curr Opin Cardiol. 2017 Jul 29. doi: 10.1097/HCO.0000000000000446.
    PubMed     Text format     Abstract available


    June 2017
  2. CHEEMA AN, Mehta SR, Verma S, Bagai A, et al
    Non-infarct related artery revascularization in ST-segment elevation myocardial infarction patients with multivessel disease.
    Curr Opin Cardiol. 2017 Jun 15. doi: 10.1097/HCO.0000000000000427.
    PubMed     Text format     Abstract available


    May 2017
  3. MANCINI GBJ, Farkouh M, Verma S
    Revascularization for patients with diabetes mellitus and stable ischemic heart disease: an update.
    Curr Opin Cardiol. 2017 May 19. doi: 10.1097/HCO.0000000000000421.
    PubMed     Text format     Abstract available


    September 2016
  4. TAQUETI VR, Di Carli MF
    Clinical significance of noninvasive coronary flow reserve assessment in patients with ischemic heart disease.
    Curr Opin Cardiol. 2016.
    PubMed     Text format     Abstract available


    July 2016
  5. RALLIDIS LS, Pavlakis G
    The fundamental importance of smoking cessation in those with premature ST-segment elevation acute myocardial infarction.
    Curr Opin Cardiol. 2016.
    PubMed     Text format     Abstract available


    January 2016
  6. BALDINGER SH, Stevenson WG, John RM
    Ablation of ischemic ventricular tachycardia: evidence, techniques, results, and future directions.
    Curr Opin Cardiol. 2016;31:29-36.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: